Sodium dihydrogencitrate - CAS 18996-35-5
Catalog: |
BB014684 |
Product Name: |
Sodium dihydrogencitrate |
CAS: |
18996-35-5 |
Synonyms: |
sodium;3-carboxy-3,5-dihydroxy-5-oxopentanoate |
IUPAC Name: | sodium;3-carboxy-3,5-dihydroxy-5-oxopentanoate |
Description: | Sodium dihydrogencitrate (CAS# 18996-35-5) is known as a commodity chemical. |
Molecular Weight: | 214.11 |
Molecular Formula: | C6H7NaO7 |
Canonical SMILES: | C(C(=O)O)C(CC(=O)[O-])(C(=O)O)O.[Na+] |
InChI: | InChI=1S/C6H8O7.Na/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+1/p-1 |
InChI Key: | HWPKGOGLCKPRLZ-UHFFFAOYSA-M |
Boiling Point: | 309.6 °C at 760 mmHg |
Melting Point: | 212°C(lit.) |
Flash Point: | 155.2°C |
Solubility: | H2O |
Appearance: | White powder |
MDL: | MFCD00013067 |
LogP: | -2.58320 |
pH: | Between 3,5 and 3,8 (1 % aqueous solution) |
GHS Hazard Statement: | H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] |
Precautionary Statement: | P264, P280, P305+P351+P338, and P337+P313 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-10980756-B1 | Methods of treatment | 20200316 |
WO-2021123085-A1 | Incontinence article with ph regulator | 20191220 |
WO-2021127235-A1 | Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same | 20191220 |
US-2021186842-A1 | Surfactants for use in personal care and cosmetic products | 20191219 |
WO-2021126667-A1 | Surfactants for use in personal care and cosmetic products | 20191219 |
PMID | Publication Date | Title | Journal |
23121941 | 20130116 | Effect of PEG-salt mixture on the gelation temperature and morphology of MC gel for sustained delivery of drug | Carbohydrate polymers |
22884434 | 20121201 | Synergistic effect of salt mixture on the gelation temperature and morphology of methylcellulose hydrogel | International journal of biological macromolecules |
22566297 | 20121101 | Rapidly serum-degradable hydrogel templating fabrication of spherical tissues and curved tubular structures | Biotechnology and bioengineering |
22706677 | 20120901 | Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins | Cellular & molecular biology letters |
22713548 | 20120815 | Citrate, not phosphate, can dissolve calcium oxalate monohydrate crystals and detach these crystals from renal tubular cells | European journal of pharmacology |
Complexity: | 251 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 214.00894684 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 7 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 214.00894684 |
Rotatable Bond Count: | 5 |
Topological Polar Surface Area: | 135 Å2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS